The bill amends Chapter 40-8 of the General Laws, introducing a new section, 40-8-33, which establishes minimum obesity coverage standards in the Medicaid program. Effective July 1, 2025, the Medicaid program will be required to provide comprehensive coverage for the treatment of obesity. This includes coverage for obesity prevention and wellness, nutrition counseling, intensive behavioral therapy, bariatric surgery, and FDA-approved anti-obesity medications. The bill specifies that the coverage criteria for these medications cannot be more restrictive than the FDA-approved indications and must align with coverage for other illnesses regarding deductibles, copayments, and coinsurance.

Additionally, the bill mandates that the Medicaid program notify enrollees and healthcare providers about the new coverage requirements in writing, ensuring that this information is disseminated in 2025 and 2026. The executive office of health and human services is also authorized to apply for necessary waivers from the U.S. Department of Health and Human Services to facilitate the implementation of this program. Overall, the bill aims to enhance access to obesity treatment within the Medicaid framework, addressing a significant public health issue.